Celebrex may slow colon cancer

Aug 31, 2006

Two U.S. studies say Pfizer's painkiller Celebrex can slow the recurrence of polyps in the colon for those at a higher risk of developing colon cancer.

But they also caution about an increased risk of heart attacks and strokes from the medicine, reports the Wall Street Journal.

The findings of the studies are published in this week's edition of the New England Journal of Medicine. Celebrex is commonly taken to relieve arthritis pain.

An editorial in the medical journal said because of the cardiovascular risk, Celebrex, or its generic version, has "no role" in preventing cancer in those who don't face high risk of colon cancer, the report said. Early testing is recommended for discovering polyps so they can be removed.

A Pfizer expert was quoted as saying the cancer results are encouraging but added, "We do not recommend Celebrex in treating and preventing cancer." He said the medicine, however, remains an important treatment option for arthritis sufferers.

Copyright 2006 by United Press International

Explore further: Pupil response predicts depression risk in kids

Related Stories

When is a drug too risky to stay on the market?

Jun 30, 2010

(AP) -- The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to ...

Can Celebrex prevent cancer-causing colon polyps?

May 13, 2010

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable ...

Recommended for you

Mammography benefits overestimated, review says

8 hours ago

An in-depth review of randomised trials on screening for breast, colorectal, cervical, prostate and lung cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are li ...

'Beyond aid' in health care: Is it time for scrutiny?

8 hours ago

The UK government's investments in private hospital chains in developing countries, in the form of 'beyond aid' approaches, could actually be hindering inclusive development and need greater scrutiny, argue experts in The BM ...

Landmark ruling in Argentine death-with-dignity case

9 hours ago

Relatives of an Argentine man who has been in a vegetative state for over 20 years can disconnect him from life support, the Supreme Court said Tuesday in a landmark ruling that divided the country.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.